All Stories

  1. ATIC Knockdown Reduces B7-H3 Expression and Oncogenic Signaling in Upper Tract Urothelial Carcinoma Cells
  2. MYCBP2 Expression Correlates With Poor Prognosis in Upper Tract Urothelial Carcinoma Patients
  3. MicroRNA‐299‐3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma
  4. MicroRNA‐145‐5p suppresses cell proliferation, migration, and invasion in upper tract urothelial carcinoma by targeting 5‐aminoimidazole‐4‐carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
  5. High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial Carcinomas
  6. MicroRNA-145-5p modulates Krüppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma
  7. High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
  8. MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1
  9. High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma
  10. MicroRNA‐145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6
  11. CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
  12. The prognostic value of CSN6 expression in upper tract urothelial carcinomas
  13. Prognostic Value of Leptin Receptor Overexpression in Upper Tract Urothelial Carcinomas in Taiwan
  14. Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma
  15. Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
  16. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells
  17. Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer
  18. Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines